Spectrum Management Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-695
Closed -$61K 264
2020
Q2
$61K Hold
695
0.02% 137
2020
Q1
$57K Hold
695
0.02% 121
2019
Q4
$66K Hold
695
0.03% 140
2019
Q3
$60K Hold
695
0.02% 135
2019
Q2
$63K Sell
695
-81
-10% -$6.86K 0.02% 145
2019
Q1
$67K Buy
+776
New +$62.3K 0.02% 125
2017
Q4
Sell
-15
Closed -$1K 354
2017
Q3
$1K Buy
+15
New +$1.13K ﹤0.01% 332
2015
Q1
Sell
-169
Closed -$14K 133
2014
Q4
$14K Hold
169
0.01% 95
2014
Q3
$14K Hold
169
0.01% 93
2014
Q2
$14K Hold
169
0.01% 97
2014
Q1
$13K Hold
169
0.01% 98
2013
Q4
$12K Buy
+169
New +$11.7K 0.01% 112

Other funds holding NVS

Spectrum Management Group's NVS Position: Q3 2020 in Review

Spectrum Management Group sold out of Novartis (NVS) in Q3 2020, closing a stake of 695 shares — an estimated $61K sold.

Spectrum Management Group first reported a position in NVS in Q4 2013 and held it in 12 quarters. The position peaked at $67K in Q1 2019. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • Spectrum Management Group reported no remaining Novartis position as of Q3 2020 after selling out during the quarter.
  • Spectrum Management Group sold 695 Novartis shares in Q3 2020, an estimated $61K.
  • Spectrum Management Group first reported a position in Novartis in Q4 2013 and held it in 12 quarters.
  • Spectrum Management Group's Novartis position peaked at $67K in Q1 2019.
  • 1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Spectrum Management Group's 13F filing for Q3 2020, filed 5 Nov 2020.